Search - tctmd.com

Displaying 241 - 260 of 530

Sort: Relevancy | Date

News Industry News

Medtronic's Valiant® Thoracic Stent Graft System Demonstrates Durability After Five Years

October 05, 2015

News Industry News

Boston Scientific Receives FDA Approval For SYNERGY™ Bioabsorbable Polymer Drug-Eluting Stent System

October 05, 2015

News Industry News

HeartMate 3™ CE Mark Trial Meets Primary Endpoint

September 28, 2015

News Industry News

Extended Follow-Up Of ANTHEM-HF Patients Shows That Benefits Of Autonomic Regulation Therapy Are Maintained After 12 Months

September 28, 2015

News Daily News

Registro OLIVE: ‘Razonables’ Resultados del Tratamiento Endovascular para el Manejo de la ICE a los 3 Años

L.A. McKeown

September 23, 2015

News Daily News

OLIVE登记处：3年时的CLI血管内临床治疗结果“合情合理”

L.A. McKeown

September 23, 2015

News Daily News

OLIVE Registry: Endovascular Therapy Outcomes for CLI ‘Reasonable’ at 3 Years

L.A. McKeown

September 23, 2015

News Daily News

Un Estudio de Registro Vincula las PCI por OTC a una Mejor Supervivencia vs. Tratamiento Médico y CABG

September 17, 2015

News Daily News

Registry Study Links CTO PCI to Improved Survival vs Medical Therapy, CABG

September 17, 2015

News Conference News ESC 2015

Registry Provides Support for Use of MitraClip in Lower-Risk Patients

L.A. McKeown

September 01, 2015

News Industry News

Abbott Announces Positive Results Of Its Naturally Dissolving Stent From Absorb Japan Study

September 01, 2015

News Daily News

No Disadvantage for 2-Stent Strategy in Bifurcation Lesions With Second-Generation DES

Yael L. Maxwell

August 26, 2015

News Daily News

Small Series Positive for Novel Transcatheter Mitral Valve in Functional MRPequeña Serie Positiva para una Nueva Válvula Mitral Transcatéter en el Manejo de la RM Funcional

August 25, 2015

News Daily News

Small Series Positive for Novel Transcatheter Mitral Valve in Functional MR

August 25, 2015

News Industry News

Acute Pulmonary Embolism Trial (SEATTLE II) Published in the JACC: Cardiovascular Interventions

August 24, 2015

News Daily News

ILUMIEN I Published: OCT Can Affect PCI Strategy

L.A. McKeown

August 17, 2015

News Daily News

ILUMIEN I Publicado: La TCO puede Influir en la Estrategia PCI

L.A. McKeown

August 17, 2015

News Daily News

钙化评分为零“保证”了无症状患者 15 年死亡率

August 06, 2015

News Daily News

Una Puntuación de Calcio Igual a 0 Ofrece una ‘Ventaja’ sobre la Mortalidad de 15 Años de Duración en Pacientes Asintomáticos

August 06, 2015

News Industry News

Celyad Completes Final Patient Infusion in CHART-1 Phase III Trial

August 03, 2015

Advertisement

Medtronic's Valiant® Thoracic Stent Graft System Demonstrates Durability After Five Years

Boston Scientific Receives FDA Approval For SYNERGY™ Bioabsorbable Polymer Drug-Eluting Stent System

HeartMate 3™ CE Mark Trial Meets Primary Endpoint

Extended Follow-Up Of ANTHEM-HF Patients Shows That Benefits Of Autonomic Regulation Therapy Are Maintained After 12 Months

Registro OLIVE: ‘Razonables’ Resultados del Tratamiento Endovascular para el Manejo de la ICE a los 3 Años

OLIVE登记处：3年时的CLI血管内临床治疗结果“合情合理”

OLIVE Registry: Endovascular Therapy Outcomes for CLI ‘Reasonable’ at 3 Years

Un Estudio de Registro Vincula las PCI por OTC a una Mejor Supervivencia vs. Tratamiento Médico y CABG

Registry Study Links CTO PCI to Improved Survival vs Medical Therapy, CABG

Registry Provides Support for Use of MitraClip in Lower-Risk Patients

Abbott Announces Positive Results Of Its Naturally Dissolving Stent From Absorb Japan Study

No Disadvantage for 2-Stent Strategy in Bifurcation Lesions With Second-Generation DES

Small Series Positive for Novel Transcatheter Mitral Valve in Functional MRPequeña Serie Positiva para una Nueva Válvula Mitral Transcatéter en el Manejo de la RM Funcional

Small Series Positive for Novel Transcatheter Mitral Valve in Functional MR

Acute Pulmonary Embolism Trial (SEATTLE II) Published in the JACC: Cardiovascular Interventions

ILUMIEN I Published: OCT Can Affect PCI Strategy

ILUMIEN I Publicado: La TCO puede Influir en la Estrategia PCI

钙化评分为零“保证”了无症状患者 15 年死亡率

Una Puntuación de Calcio Igual a 0 Ofrece una ‘Ventaja’ sobre la Mortalidad de 15 Años de Duración en Pacientes Asintomáticos

Celyad Completes Final Patient Infusion in CHART-1 Phase III Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content